Al Hammadi Holding Company (4007.SR)
- Previous Close
57.70 - Open
57.80 - Bid 56.60 x --
- Ask 56.70 x --
- Day's Range
56.10 - 57.90 - 52 Week Range
47.95 - 71.80 - Volume
622,741 - Avg. Volume
965,123 - Market Cap (intraday)
9.088B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
29.89 - EPS (TTM)
1.90 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield 1.05 (1.85%)
- Ex-Dividend Date Mar 26, 2024
- 1y Target Est
58.80
Al Hammadi Holding Company, a healthcare group, provides various medical services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It engages in the sale of pharmaceutical products. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in August 2022. Al Hammadi Holding Company was founded in 1985 and is based in Riyadh, Saudi Arabia.
www.alhammadi.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 4007.SR
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4007.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4007.SR
Valuation Measures
Market Cap
9.09B
Enterprise Value
9.28B
Trailing P/E
29.89
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.72
Price/Book (mrq)
4.93
Enterprise Value/Revenue
7.88
Enterprise Value/EBITDA
20.76
Financial Highlights
Profitability and Income Statement
Profit Margin
25.78%
Return on Assets (ttm)
8.44%
Return on Equity (ttm)
17.06%
Revenue (ttm)
1.18B
Net Income Avi to Common (ttm)
303.33M
Diluted EPS (ttm)
1.90
Balance Sheet and Cash Flow
Total Cash (mrq)
125.24M
Total Debt/Equity (mrq)
17.03%
Levered Free Cash Flow (ttm)
179.08M
Research Analysis: 4007.SR
Company Insights: 4007.SR
4007.SR does not have Company Insights